A Dosimetric Comparison of HyperArc Therapy Planning and Volumetric Modulated Arc Therapy Planning in Treating Patients With Glioblastoma Multiforme
In Vivo · 2025
DOI: 10.21873/invivo.13906 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift In Vivo, 2025. Verfasst von Wei-Ju Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Glioblastoma, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Intensity-Modulated, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: This study aimed at evaluating the potential benefit of automatic non-coplanar volumetric arc therapy (VMAT) (hyperarc, HA) technique in treating glioblastoma multiforme (GBM). Patients and Methods: Twenty-seven patients with GBM who received coplanar VMAT (C-VMAT) were selected in this study. HA and non-coplanar VMAT (NC-VMAT) plans were generated with the same prescriptions and constraints. The Target coverage, organs at risk (OARs) dose, and dosimetric indexes were compared among three plans.
Results
The HA plan demonstrated a reduction in dose to normal tissues while maintaining target coverage, compared to C-VMAT and NC-VMAT. Additionally, HA plans demonstrated higher coverage of the GTV and PTV60 as well as improved CI from PTV60 and PTV46 compared to the other plans. Regarding the dose gradient, HA plans showed a greater dose fall-off, resulting in reduced high-dose and intermediate-dose spillage at PTV46. The HA also demonstrated a tighter gradient radius at PTV60 and PTV46. The HA plan requires fewer MUs than both C-VMAT and NC-VMAT.
Conclusion
The HA plan had better dosimetric results compared to C-VMAT and NC-VMAT. The HA with automatic planning module and auto-delivery treatment also provided high-quality planning and delivery efficacy. These advantages suggest that HA could potentially escalate tumor doses while minimizing toxicity, thereby improving outcomes in GBM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.
- Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.; cleanclear0905@gmail.com.
- Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan, R.O.C.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan, R.O.C.
- Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan, R.O.C.; liching51@yahoo.com.tw.
Zitieren
APA
Hong, W. J., Ho, H. W., Lin, H. M., Lin, T., Chow, W. H., Yang, C. C., & Lin, L. C. (2025). A Dosimetric Comparison of HyperArc Therapy Planning and Volumetric Modulated Arc Therapy Planning in Treating Patients With Glioblastoma Multiforme. In Vivo. https://doi.org/10.21873/invivo.13906
Vancouver
Hong WJ, Ho HW, Lin HM, Lin T, Chow WH, Yang CC, et al. A Dosimetric Comparison of HyperArc Therapy Planning and Volumetric Modulated Arc Therapy Planning in Treating Patients With Glioblastoma Multiforme. In Vivo. 2025. doi:10.21873/invivo.13906
BibTeX
@article{Hong2025,
author = {Hong, Wei-Ju and Ho, Hsiu-Wen and Lin, Hsiu-Man and Lin, Tung and Chow, Wan-Hsuan and Yang, Ching-Chieh and Lin, Li-Ching},
title = {A Dosimetric Comparison of HyperArc Therapy Planning and Volumetric Modulated Arc Therapy Planning in Treating Patients With Glioblastoma Multiforme},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.13906}
}
EUVIMED